Approval · Notice of Compliance 37711 · 2026
HULIO: Notice of Compliance 37711
Issued June 16, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37711
- Date
- June 16, 2026
- Company
- Biocon Biologics Canada IncToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative – Manufacturer name change
- Canadian reference product
- HUMIRA
Products in this notice
Medicinal ingredients
- ADALIMUMAB 20 MG per SYR
- ADALIMUMAB 40 MG per SYR
- ADALIMUMAB 40 MG per PEN